Business Description
Oncimmune Holdings PLC
ISIN : GB00BYQ94H38
Description
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | -0.22 | |||||
| Debt-to-Equity | -4.12 | |||||
| Debt-to-EBITDA | -2.25 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.33 | |||||
| Beneish M-Score | 2.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26 | |||||
| 3-Year EBITDA Growth Rate | 24.5 | |||||
| 3-Year EPS without NRI Growth Rate | 15.7 | |||||
| 3-Year FCF Growth Rate | 13.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.07 | |||||
| 9-Day RSI | 32.65 | |||||
| 14-Day RSI | 39.17 | |||||
| 6-1 Month Momentum % | -35.15 | |||||
| 12-1 Month Momentum % | -45.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.14 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 269.58 | |||||
| Days Sales Outstanding | 362.49 | |||||
| Days Payable | 786.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.3 | |||||
| Shareholder Yield % | 31.19 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.34 | |||||
| Operating Margin % | -133.2 | |||||
| Net Margin % | 581.63 | |||||
| FCF Margin % | -505.44 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 95.16 | |||||
| ROIC % | -25.55 | |||||
| ROC (Joel Greenblatt) % | -294.86 | |||||
| ROCE % | -75.99 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.29 | |||||
| Forward PE Ratio | 76.75 | |||||
| Price-to-Owner-Earnings | 2.37 | |||||
| PS Ratio | 9.26 | |||||
| EV-to-EBIT | -7.72 | |||||
| EV-to-Forward-EBIT | 41.68 | |||||
| EV-to-EBITDA | -8.91 | |||||
| EV-to-Forward-EBITDA | 29.77 | |||||
| EV-to-Revenue | 17.15 | |||||
| EV-to-Forward-Revenue | 3.02 | |||||
| EV-to-FCF | -3.47 | |||||
| Earnings Yield (Greenblatt) % | -12.94 | |||||
| FCF Yield % | -37.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oncimmune Holdings PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 1.214 | ||
| EPS (TTM) (£) | 0.115 | ||
| Beta | 1.84 | ||
| Volatility % | 121 | ||
| 14-Day RSI | 39.17 | ||
| 14-Day ATR (£) | 0.007372 | ||
| 20-Day SMA (£) | 0.1527 | ||
| 12-1 Month Momentum % | -45.42 | ||
| 52-Week Range (£) | 0.0935 - 0.31 | ||
| Shares Outstanding (Mil) | 111.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oncimmune Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncimmune Holdings PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oncimmune Holdings PLC Frequently Asked Questions
What is Oncimmune Holdings PLC(LSE:ONC)'s stock price today?
The current price of LSE:ONC is £0.15. The 52 week high of LSE:ONC is £0.31 and 52 week low is £0.09.
When is next earnings date of Oncimmune Holdings PLC(LSE:ONC)?
The next earnings date of Oncimmune Holdings PLC(LSE:ONC) is 2025-02-28 Est..
Does Oncimmune Holdings PLC(LSE:ONC) pay dividends? If so, how much?
Oncimmune Holdings PLC(LSE:ONC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers